Login
$MRKR
$0.82 -$0.01 (1.04%) After hours

Company Executives

Officer Age In this role Joined Source
Juan Vera Also a director
Chief Executive Officer
Title from the Form 4 dated Oct 31, 2025
46 Not stated Not stated
Maria-Bernadette Madel
Director of Corporate Operations and External Communications
Not stated Since 2023
3 years
2022

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
5
serving now
Independent
4 of 4
stated in the proxy; 1 not stated
Average tenure
7.0 years
from year joined
CEO also chairs the board
No
David Eansor
Director Age On board Independent Other public boards 2025 pay Source
David Eansor
65 2018
8 years
Independent None stated $308,385
Juan Vera
46 2018
8 years
Not stated None stated Paid as CEO
Steven Elms
62 2019
7 years
Independent ADMA Biologics, Inc. $261,885
Katharine Knobil
62 2021
5 years
Independent KorroBio, Inc., Pliant Therapeutics, Inc. $269,885
Kathryn Penkus Corzo
64 Not stated Independent None stated $130,000

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

7 disclosed in the proxy filed Mar 20, 2026
John Wilson
former member of our board of directors; CEO of Wilson Wolf Manufacturing Corporation
$277,000
2023

Purchases of cell culture devices (G-Rexes) from Wilson Wolf Manufacturing Corporation

With Wilson Wolf Manufacturing Corporation Open in proxy
John Wilson
former director; owner of Cell Ready, LLC
$19.0 million
2023

Sale of Manufacturing Facilities leases, equipment and related contracts (Purchased Assets) to Cell Ready

With Cell Ready, LLC Open in proxy
John Wilson
former director; owner of Cell Ready, LLC
Amount not stated
2024

Master Services Agreement under which Cell Ready provided CDMO services, including GMP drug product manufacturing

With Cell Ready, LLC Open in proxy
John Wilson
former director; owner of Cell Ready, LLC
Approximately $1.3M
2023

Payments to Cell Ready for outsourced product development and manufacturing services

With Cell Ready, LLC Open in proxy
John Wilson
former director; owner of Cell Ready, LLC
Approximately $5.5M
2024

Payments to Cell Ready for outsourced product development and manufacturing services

With Cell Ready, LLC Open in proxy
John Wilson
former director; owner of Cell Ready, LLC
Approximately $453,000
2025

Settlement and release payment to Cell Ready upon termination of the MSA

With Cell Ready, LLC Open in proxy
Juan Vera
Chief Executive Officer, President and director of the Company; served on the board of directors of AlloVir
Amount not stated
until June 2023

Services agreement under which the Company provided development services to AlloVir

With AlloVir, Inc. Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support